Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials

Journal:

Nature Communications

Published:

2026-04-03

DOI:

10.1038/s41467-026-70888-0

Affiliations:

20

Authors:

49

Go to article

Institutions	Authors	Share
Fred Hutchinson Cancer Center, United States of America (USA)	16.333333 16.333333	0.33
University of Cape Town (UCT), South Africa	9.333333	0.19
University of Washington (UW), United States of America (USA)	6.666667	0.14
National Health Laboratory Service (NHLS), South Africa	2.916667	0.06
SAMRC/NICD Antibody Immunity Research Unit, South Africa	1.916667	0.04
University of the Witwatersrand, Johannesburg (Wits University), South Africa	1.916667	0.04
Karolinska Institute (KI), Sweden	1.500000	0.03
Walter Reed Army Institute of Research (WRAIR), USAMRDC, United States of America (USA)	1.000000	0.02
Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), United States of America (USA)	1.000000	0.02
Los Alamos National Laboratory (LANL), United States of America (USA)	1.000000	0.02
Duke University Hospital, United States of America (USA)	1.000000	0.02
Emory University, United States of America (USA)	1.000000	0.02
University of Zimbabwe (UZ), Zimbabwe	1.000000	0.02
The University of North Carolina at Chapel Hill (UNC), United States of America (USA)	1.000000	0.02
UW Medicine, United States of America (USA)	0.833333	0.02
Centre for the AIDS Programme of Research in South Africa (CAPRISA), South Africa	0.583333	0.01

Interested in Clinical Sciences?